IXO Private Equity

Type

Venture Capital

Status

Active

Location

Toulouse, France

Total investments

58

Average round size

13M

Portfolio companies

49

Rounds per year

1.35

Lead investments

10

Follow on index

0.16

Exits

9

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareManufacturingMedical DeviceMedicalElectronicsInternet of ThingsWireless

Summary

IXO Private Equity appeared to be the VC, which was created in 1981. The leading representative office of defined VC is situated in the Toulouse. The company was established in Europe in France.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the IXO Private Equity, startups are often financed by Partech, Elaia, Omnes Capital. The meaningful sponsors for the fund in investment in the same round are Partech, Elaia, Omnes Capital. In the next rounds fund is usually obtained by Bpifrance, Intel Capital, Elaia.

Besides them, we counted 3 critical employees of this fund in our database.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight SuperSonic Imagine, Pole Star, Ixaltis. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most successful fund investment fields, there are Biopharma, Medical Device.

The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2018. When the investment is from IXO Private Equity the average startup value is 100-500 millions dollars. Opposing the other organizations, this IXO Private Equity works on 12 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.

Show more

Investor highlights

Industry focus
HardwareHealthcareEnergyClimate techDeep Tech Show 1 more
Geo focus
Check size
1M — 5M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
EUR 60000000
Fund raised date
2020-12-17

Analytics

Total investments
58
Lead investments
10
Exits
9
Rounds per year
1.35
Follow on index
0.16
Investments by industry
  • Manufacturing (13)
  • Health Care (11)
  • Biotechnology (9)
  • Software (8)
  • Medical Device (5)
  • Show 80 more
Investments by region
  • France (53)
  • United States (3)
  • Canada (1)
Peak activity year
2023

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
18
Avg. valuation at time of investment
11M
Group Appearance index
0.66
Avg. company exit year
15
Avg. multiplicator
0.12
Strategy success index
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Addworking 06 Oct 2021 Risk Management, Freelance Early Stage Venture 7M Ile-de-France, Paris, France
Antabio 16 Oct 2017 Biotechnology, Medical Device, Life Science Early Stage Venture 8M France, Auvergne-Rhône-Alpes

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.